Urology - European Medical Journal

Continue

Urology

Filter
22 Sep 2017

Urinary Tract Infection Resistant Mutation Identified

A MUTATION altering the effect that levofloxacin, a quinolone antibiotic, has on pathogens causing urinary tract infections (UTI) has been identified by…
22 Sep 2017

Immunotherapy to Advance Prostate Cancer Treatment

A NOVEL immunotherapy strategy for the treatment of prostate cancer using DNA-encoded monoclonal antibodies (DMAb) has shown promising results according…
21 Aug 2017

Action-Packed August

Here in the EMJ offices, August would best be described by the team as a whirlwind, with not one, but six brand new publications ready for you to choose…
26 Jun 2017

Significant Improvement in Prostate Cancer Survival Rates Found

SIGNIFICANT improvements to survival rates in prostate cancer patients have been found to result from the addition of abiraterone to hormone therapy at…
8 Jun 2017

Abiraterone Acetate Plus Prednisone Provided Significant Clinical Benefit in Patients with High-Risk Metastatic Hormone-Naïve Prostate Cancer (mHNPC), Improving Overall Survival and Radiographic Progression-Free Survival

Beerse, Belgium, 3 June, 2017 – Janssen-Cilag International NV today announced data from the pivotal Phase 3 LATITUDE clinical trial, which showed Zytiga…
3 May 2017

Mental Health Education Should Be as Important as Going to School, Expert Warns

According to recent headlines, mental health education should also be taught in schools. The recent debate has been sparked by a petition spearheaded by…
5 Apr 2017

Australia’s Bionic Vision Technologies Raises US$18 Million (AU$23.5 M) to Develop ‘Bionic Eye’ for Global Markets

Melbourne, Australia, April 03, 2017 – Retinal implant innovator Bionic Vision Technologies (BVT) today announced it had raised US $18 million…
27 Mar 2017

Pembrolizumab Improves Survival as a Second-Line Treatment for Urothelial Cancer

PEMBROLIZUMAB, a highly selective, humanised monoclonal antibody targeting programmed cell death 1 (PD-1), has a superior safety profile and improved…
We’ve noticed you’re accessing
from North/South America.